Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for 2021.
For this series, the doctors discuss new trials for patients with NSCLC. The doctors discuss the FDA Analysis of Immunotherapy +/- Chemotherapy in Patients with Advanced NSCLC and Low Tumor PD-L1 Expression
For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.